{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:24:00Z","timestamp":1789907040743,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.brainres.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T06:46:45Z","timestamp":1487918805000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: Possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling"],"prefix":"10.1016","volume":"1662","author":[{"given":"Tourandokht","family":"Baluchnejadmojarad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Rabiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Zabihnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.02.021_b0005","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s12035-014-8771-0","article-title":"Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat","volume":"51","author":"Afshin-Majd","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2017.02.021_b0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","article-title":"Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences","volume":"93","author":"Ahmad","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/10520295.2015.1078910","article-title":"Investigation of the protective effect of ellagic acid for preventing kidney injury in rats exposed to nicotine during the fetal period","volume":"91","author":"Akkoyun","year":"2016","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2017.02.021_b0025","first-page":"4507","article-title":"Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation","volume":"8","author":"Arya","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.brainres.2017.02.021_b0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.physbeh.2004.04.005","article-title":"Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test","volume":"82","author":"Baluchnejadmojarad","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2017.02.021_b0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.02.021_b0040","doi-asserted-by":"crossref","first-page":"387028","DOI":"10.1155\/2015\/387028","article-title":"Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B","volume":"2015","author":"Batassini","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.brainres.2017.02.021_b0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2741\/S415","article-title":"Parkinson's disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"10.1016\/j.brainres.2017.02.021_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2017.02.021_b0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cns.12175","article-title":"Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action","volume":"19","author":"Borah","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.brainres.2017.02.021_b0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0065","first-page":"296","article-title":"Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats. BMC Complement","volume":"15","author":"Chattopadhyaya","year":"2015","journal-title":"Altern. Med."},{"key":"10.1016\/j.brainres.2017.02.021_b0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mjt.0000174353.28012.a7","article-title":"Neuroprotective therapy in Parkinson disease","volume":"13","author":"Chen","year":"2006","journal-title":"Am. J .Ther."},{"key":"10.1016\/j.brainres.2017.02.021_b0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ijcard.2014.06.045","article-title":"Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation","volume":"175","author":"Ding","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.brainres.2017.02.021_b0080","first-page":"38","article-title":"Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson's disease","volume":"18","author":"Dolatshahi","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.brainres.2017.02.021_b0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jbt.21587","article-title":"Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats","volume":"28","author":"El-Garhy","year":"2014","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.brainres.2017.02.021_b0090","first-page":"83","article-title":"Ellagic acid protects the brain against 6-hydroxydopamine induced neuroinflammation in a rat model of Parkinson's disease","volume":"6","author":"Farbood","year":"2015","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.brainres.2017.02.021_b0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2015.01.013","article-title":"Ellagic acid prevents cognitive and hippocampal long-term potentiation deficits and brain inflammation in rat with traumatic brain injury","volume":"124","author":"Farbood","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.brainres.2017.02.021_b0100","doi-asserted-by":"crossref","first-page":"e0003","DOI":"10.5041\/RMMJ.10003","article-title":"Pharmacology of Rasagiline, a New MAO-B inhibitor drug for the treatment of Parkinson's disease with neuroprotective potential","volume":"1","author":"Finberg","year":"2010","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.brainres.2017.02.021_b0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","article-title":"Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection","volume":"97","author":"Garcia-Nino","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fitote.2015.08.001","article-title":"An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases","volume":"106","author":"Giacoppo","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.brainres.2017.02.021_b0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.intimp.2014.07.005","article-title":"Ellagic acid protects Lipopolysaccharide\/D-galactosamine-induced acute hepatic injury in mice","volume":"22","author":"Gu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.brainres.2017.02.021_b0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20150617","article-title":"Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease","volume":"471","author":"Gustot","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.brainres.2017.02.021_b0125","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3923\/pjn.2009.1661.1664","article-title":"Bioavailability of ellagic acid after single dose administration using HPLC","volume":"8","author":"Hamad","year":"2009","journal-title":"Pak. J. Nutr."},{"key":"10.1016\/j.brainres.2017.02.021_b0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jbt.20030","article-title":"The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure","volume":"18","author":"Hassoun","year":"2004","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.brainres.2017.02.021_b0135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2014.05.045","article-title":"Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat","volume":"1574","author":"Healy-Stoffel","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0140","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1271\/bbb.110842","article-title":"Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons","volume":"76","author":"Hwang","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2013.01.054","article-title":"Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism","volume":"1505","author":"Jalali-Nadoushan","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11064-015-1751-6","article-title":"Neuroprotective effects of Tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson's disease through upregulating Nrf2","volume":"41","author":"Jing","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/cn500214k","article-title":"Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers","volume":"5","author":"Kabiraj","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.brainres.2017.02.021_b0160","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.4103\/0973-1296.182168","article-title":"Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid","volume":"12","author":"Khatri","year":"2016","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.brainres.2017.02.021_b0165","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","article-title":"Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease","volume":"36","author":"Kiasalari","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2017.02.021_b0170","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11064-015-1796-6","article-title":"Protective effect of oral hesperetin against unilateral striatal 6-hydroxydopamine damage in the rat","volume":"41","author":"Kiasalari","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbrc.2005.08.020","article-title":"Heme oxygenase and heme degradation","volume":"338","author":"Kikuchi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2017.02.021_b0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2017.02.021_b0185","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.3390\/ijms130810608","article-title":"Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease","volume":"13","author":"Koppula","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2017.02.021_b0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mc.20465","article-title":"Molecular mechanisms of Nrf2-mediated antioxidant response","volume":"48","author":"Li","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.brainres.2017.02.021_b0195","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1871527314666150225124928","article-title":"Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease","volume":"14","author":"Macchi","year":"2015","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.brainres.2017.02.021_b0200","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3109\/13880209.2015.1137601","article-title":"Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments","volume":"54","author":"Mansouri","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.brainres.2017.02.021_b0205","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","article-title":"Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease","volume":"36","author":"Morroni","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2017.02.021_b0210","first-page":"749","article-title":"A systematic review of the worldwide prevalence and incidence of Parkinson's disease","volume":"94","author":"Muangpaisan","year":"2011","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.brainres.2017.02.021_b0215","first-page":"1145","article-title":"Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat","volume":"14","author":"Negahdar","year":"2015","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0220","first-page":"1153","article-title":"Ellagic acid improves electrocardiogram waves and blood pressure against global cerebral ischemia rat experimental models","volume":"7","author":"Nejad","year":"2015","journal-title":"Electron. Phys."},{"key":"10.1016\/j.brainres.2017.02.021_b0225","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1471-1931(00)00031-8","article-title":"Levodopa motor complications in Parkinson's disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2017.02.021_b0230","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1471-4159.1999.721187.x","article-title":"Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice","volume":"72","author":"Panahian","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0235","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jf0510539","article-title":"Evaluation of estrogenic\/antiestrogenic activity of ellagic acid via the estrogen receptor subtypes ERalpha and ERbeta","volume":"53","author":"Papoutsi","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.brainres.2017.02.021_b0240","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.brainres.2017.02.021_b0245","article-title":"Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides","volume":"S0301\u20130082","author":"Reglodi","year":"2015","journal-title":"Prog. Neurobiol. pii"},{"key":"10.1016\/j.brainres.2017.02.021_b0250","first-page":"51","article-title":"Extracellular alpha-synuclein\u2013a possible initiator of inflammation in Parkinson's disease","volume":"71","author":"Ren","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.brainres.2017.02.021_b0255","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2017.02.021_b0260","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12640-009-9010-8","article-title":"The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons","volume":"15","author":"Rodriguez-Pallares","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.brainres.2017.02.021_b0270","article-title":"Health benefits of walnut polyphenols: an exploration beyond their lipid profile","volume":"29","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.brainres.2017.02.021_b0275","first-page":"689","article-title":"Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions","volume":"18","author":"Schwarting","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2017.02.021_b0280","first-page":"227","article-title":"Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model","volume":"13","author":"Sedaghat","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0285","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/jphp.12589","article-title":"Ellagic acid confers protection against gentamicin-induced oxidative damage, mitochondrial dysfunction and apoptosis-related nephrotoxicity","volume":"68","author":"Sepand","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.brainres.2017.02.021_b0290","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6","article-title":"Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system","volume":"388","author":"Shughrue","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2017.02.021_b0295","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.4103\/1673-5374.165228","article-title":"Transforming growth factor beta1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?","volume":"10","author":"Spittau","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.brainres.2017.02.021_b0300","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjp.2008.342","article-title":"Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders","volume":"155","author":"Syapin","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2017.02.021_b0305","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.freeradbiomed.2012.06.040","article-title":"S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades","volume":"53","author":"Tobon-Velasco","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2017.02.021_b0310","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10072-011-0775-1","article-title":"Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats","volume":"33","author":"Uzar","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.brainres.2017.02.021_b0315","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jnutbio.2012.03.005","article-title":"The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism","volume":"23","author":"Vomhof-Dekrey","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.brainres.2017.02.021_b0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2015.12.024","article-title":"The influence of common free radicals and antioxidants on development of Alzheimer's Disease","volume":"78","author":"Wojtunik-Kulesza","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainres.2017.02.021_b0325","doi-asserted-by":"crossref","first-page":"18923","DOI":"10.3390\/molecules191118923","article-title":"Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS\/MS)","volume":"19","author":"Yan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.brainres.2017.02.021_b0330","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.brainres.2017.02.021_b0335","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-014-9604-6","article-title":"The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat","volume":"30","author":"Zare","year":"2015","journal-title":"Metab. Brain Dis."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317300926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317300926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T02:56:38Z","timestamp":1536029798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317300926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":67,"alternative-id":["S0006899317300926"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: Possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}